Dr Topp on the Efficacy of Glofitamab Plus R-CHOP in Previously Untreated DLBCL - OncLive
Max S. Topp, MD, discusses the efficacy of the combination of glofitamab plus R-CHOP from a phase 1 trial done in previously untreated patients with diffuse large B-cell lymphoma. - READ MORE
